Caristo Diagnostics has announced University of Oxford-led research showing that coronary inflammation assessment can improve cardiovascular risk prediction beyond coronary artery calcium scoring and conventional risk factors.
Published in JAMA Cardiology, the study evaluated the fat attenuation index (FAI) score, a measure underpinning Caristo’s CaRi-Heart technology. The approach analyses fat surrounding the coronary arteries to assess inflammatory changes associated with cardiovascular risk.
The researchers also developed an artificial intelligence algorithm to measure FAI scores from non-contrast cardiac CT scans, which are routinely used for calcium scoring. This application remains investigational.
The algorithm’s development cohort included 6,818 individuals, followed by external validation in 19,110 patients. Median follow-up was 6.7 years. The validation cohort recorded 536 cardiovascular deaths and 1,727 major adverse cardiovascular events.
Patients with calcium scores below 100 accounted for approximately 42% of cardiovascular deaths and 51% of major adverse cardiovascular events. The findings highlight residual risk among people whose calcium burden might otherwise suggest a comparatively favourable outlook.
Adding inflammation assessment improved risk discrimination beyond calcium scoring alone. The area under the curve increased from 0.76 to 0.81 with FAI measured from coronary CT angiography, and to 0.80 with the investigational non-contrast approach.
Among patients with a calcium score of zero who subsequently died from cardiovascular causes, approximately 45% had a non-contrast FAI score above the 75th percentile.
Professor Charalambos Antoniades, the study’s senior author, said inflammation provides information about disease activity beyond the accumulated calcium and plaque visible on scans.
The findings support further investigation of inflammation-based assessment in preventive cardiology. They establish prognostic associations rather than demonstrating that using the technology directly reduces cardiovascular events.
Caristo’s existing CaRi-Heart platform analyses coronary CT angiography images. Its proposed extension to non-contrast scans is distinct from that established application.